These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9254630)

  • 21. Lipopolysaccharides in bacterial membranes act like cholesterol in eukaryotic plasma membranes in providing protection against melittin-induced bilayer lysis.
    Allende D; McIntosh TJ
    Biochemistry; 2003 Feb; 42(4):1101-8. PubMed ID: 12549932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of a recombinant amino terminal fragment of bactericidal/permeability increasing protein in rodents challenged with LPS or E. coli bacteria.
    Kung AH; Ammons WS; Lin Y; Kohn FR
    Prog Clin Biol Res; 1994; 388():255-63. PubMed ID: 7831363
    [No Abstract]   [Full Text] [Related]  

  • 23. Gram-negative outer and inner membrane models: insertion of cyclic cationic lipopeptides.
    Clausell A; Garcia-Subirats M; Pujol M; Busquets MA; Rabanal F; Cajal Y
    J Phys Chem B; 2007 Jan; 111(3):551-63. PubMed ID: 17228913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of lipopolysaccharide (LPS) chain length on interactions of bactericidal/permeability-increasing protein and its bioactive 23-kilodalton NH2-terminal fragment with isolated LPS and intact Proteus mirabilis and Escherichia coli.
    Capodici C; Chen S; Sidorczyk Z; Elsbach P; Weiss J
    Infect Immun; 1994 Jan; 62(1):259-65. PubMed ID: 8262637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective effects of an N-terminal fragment of bactericidal/permeability-increasing protein in rodent models of gram-negative sepsis: role of bactericidal properties.
    Ammons WS; Kohn FR; Kung AH
    J Infect Dis; 1994 Dec; 170(6):1473-82. PubMed ID: 7995987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospects for use of recombinant BPI in the treatment of gram-negative bacterial infections.
    Elsbach P; Weiss J
    Infect Agents Dis; 1995 Jun; 4(2):102-9. PubMed ID: 7613727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A synthetic peptide derived from bactericidal/permeability-increasing protein neutralizes endotoxin in vitro and in vivo.
    Jiang Z; Hong Z; Guo W; Xiaoyun G; Gengfa L; Yongning L; Guangxia X
    Int Immunopharmacol; 2004 Apr; 4(4):527-37. PubMed ID: 15099530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Probing the properties of lipopolysaccharide monolayers and their interaction with the antimicrobial peptide polymyxin B by atomic force microscopy.
    Roes S; Seydel U; Gutsmann T
    Langmuir; 2005 Jul; 21(15):6970-8. PubMed ID: 16008411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The BPI/LBP family of proteins: a structural analysis of conserved regions.
    Beamer LJ; Carroll SF; Eisenberg D
    Protein Sci; 1998 Apr; 7(4):906-14. PubMed ID: 9568897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phospholipid flop induced by transmembrane peptides in model membranes is modulated by lipid composition.
    Kol MA; van Laak AN; Rijkers DT; Killian JA; de Kroon AI; de Kruijff B
    Biochemistry; 2003 Jan; 42(1):231-7. PubMed ID: 12515559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The interaction of arginine- and tryptophan-rich cyclic hexapeptides with Escherichia coli membranes.
    Junkes C; Wessolowski A; Farnaud S; Evans RW; Good L; Bienert M; Dathe M
    J Pept Sci; 2008 Apr; 14(4):535-43. PubMed ID: 17985396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The endotoxin-binding bactericidal/permeability-increasing protein (BPI): a target antigen of autoantibodies.
    Schultz H; Weiss J; Carroll SF; Gross WL
    J Leukoc Biol; 2001 Apr; 69(4):505-12. PubMed ID: 11310835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual mechanism of bacterial lethality for a cationic sequence-random copolymer that mimics host-defense antimicrobial peptides.
    Epand RF; Mowery BP; Lee SE; Stahl SS; Lehrer RI; Gellman SH; Epand RM
    J Mol Biol; 2008 May; 379(1):38-50. PubMed ID: 18440552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. From infection to autoimmunity: a new model for induction of ANCA against the bactericidal/permeability increasing protein (BPI).
    Schultz H
    Autoimmun Rev; 2007 Mar; 6(4):223-7. PubMed ID: 17317612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular mechanisms of polymyxin B-membrane interactions: direct correlation between surface charge density and self-promoted transport.
    Wiese A; Münstermann M; Gutsmann T; Lindner B; Kawahara K; Zähringer U; Seydel U
    J Membr Biol; 1998 Mar; 162(2):127-38. PubMed ID: 9538506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular mechanisms of interaction of rabbit CAP18 with outer membranes of gram-negative bacteria.
    Gutsmann T; Larrick JW; Seydel U; Wiese A
    Biochemistry; 1999 Oct; 38(41):13643-53. PubMed ID: 10521271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bacterial modification of LPS and resistance to antimicrobial peptides.
    Gunn JS
    J Endotoxin Res; 2001; 7(1):57-62. PubMed ID: 11521084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endotoxin: physical requirements for cell activation.
    Mueller M; Lindner B; Dedrick R; Schromm AB; Seydel U
    J Endotoxin Res; 2005; 11(5):299-303. PubMed ID: 16263003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A study on bactericidal/permeability increasing protein (BPI) as a natural inhibitor of endotoxin].
    Zhou H
    Zhonghua Shao Shang Za Zhi; 2001 Apr; 17(2):102-4. PubMed ID: 11876922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of a recombinant modified amino terminal fragment of bactericidal/permeability-increasing protein (rBPI21) in healthy volunteers.
    Bauer RJ; Wedel N; Havrilla N; White M; Cohen A; Carroll SF
    J Clin Pharmacol; 1999 Nov; 39(11):1169-76. PubMed ID: 10579148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.